poisar

Stocks · News reference

Guggenheim Maintains Buy on Danaher, Lowers Price Target to $200

Jul 22, 2026, 4:31 PMBenzinga Newsdesk

Guggenheim analyst Subbu Nambi maintains Danaher (NYSE:DHR) with a Buy and lowers the price target from $235 to $200.

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

DHR
Source
benzinga
Observed
Jul 22, 2026, 4:31 PM
Checked
Jul 22, 2026, 4:31 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Aug 27, 2026, 3:00 PMSns Insider

    Laboratory Informatics Market to Grow from USD 4.08 Billion in 2025 to USD 6.69 Billion by 2035, at a CAGR of 5.06% - SNS Insider

    The global laboratory informatics market is projected to grow at a CAGR of 5.06% from 2025 to 2035, driven by increased data processing demands, regulatory compliance requirements, and adoption of cloud-native solutions and AI-driven analytics. North America leads with 42.55% market share, while Asia-Pacific is the fastest-growing region. Services and LIMS products dominate, with cloud delivery and electronic lab notebooks showing the strongest growth rates.

    Read original at globenewswire-inc
    TMOAABTWATDHR
  4. Aug 3, 2026, 8:27 PMSEC EDGAR

    8-K filing — DANAHER CORP /DE/ (DHR)

    Filed: 2026-08-03 AccNo: 0001193125-26-330652 Size: 845 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

    Read original at edgar
    DHR